The choices women make about prenatal diagnosis
- PMID: 11653025
- DOI: 10.1159/000263875
The choices women make about prenatal diagnosis
Abstract
Despite the rapid advancement and increasing utilization of prenatal diagnostic technologies, there has been a paucity of investigation into the psychological, socioeconomic, and demographic features associated with the choices women make about both the uptake of services, and the actions taken after fetal abnormalities are discovered. From 1986 through 1991 we have completed four studies initiating a proposed comprehensive evaluation of these factors. The first two studies concentrated on patient features influencing uptake of prenatal diagnostic procedures in both a priori 'high risk' pregnancies (advanced maternal age) as well as in previously 'low risk' pregnancies which had become 'high risk' by virtue of abnormal maternal alpha-fetoprotein (MSAFP) screening. The second two studies evaluated features influencing abortion decisions after the discovery of either chromosomal anomalies, or non-aneuploid ultrasonographically detected structural abnormalities. Data suggested that (1) older and more highly educated women tended to choose CVS over amniocentesis; (2) perceptions of genetic risk within couples was most influenced by attributes of their partners; (3) anxiety and perception of risk was higher in young women having abnormal screening MSAFP, than in the advanced maternal age group although this difference appeared to be commensurate with actual risks; (4) for fetal aneuploidy, the specific karyotype and, to a lesser extent, coexistent structural anomalies are the major determinants of decisions to abort; (5) for euploid fetal structural abnormalities the prognostic severity and potential for beneficial medical intervention (either antenatally or postnatally) as counselled by the physician were the principal determinants influencing abortion decisions. Further study is needed and important questions still to be addressed are discussed.
Similar articles
-
Prenatal diagnosis: choices women make about pursuing testing and acting on abnormal results.Clin Obstet Gynecol. 1993 Sep;36(3):469-509. Clin Obstet Gynecol. 1993. PMID: 11643167 No abstract available.
-
Prenatal diagnosis: choices women make about pursuing testing and acting on abnormal results.Clin Obstet Gynecol. 1993 Sep;36(3):496-509. doi: 10.1097/00003081-199309000-00008. Clin Obstet Gynecol. 1993. PMID: 8403601 Review.
-
Psychosocial issues in reproductive genetic testing and pregnancy loss.Fetal Diagn Ther. 1993 Apr;8(Suppl. 1):164-73. doi: 10.1159/000263884. Fetal Diagn Ther. 1993. PMID: 11653016 Review.
-
A 35-year-old pregnant woman considering maternal serum screening and amniocentesis.JAMA. 1996 May 8;275(18):1440-6. JAMA. 1996. PMID: 8618372 No abstract available.
-
Response to termination of pregnancy for genetic reasons.Z Kinderchir. 1983 Dec;38(2):98-9. Z Kinderchir. 1983. PMID: 11653715 No abstract available.
Cited by
-
Embodied Knowledge and Making Sense of Prenatal Diagnosis.J Genet Couns. 1999 Oct;8(5):255-74. doi: 10.1023/A:1022901131305. J Genet Couns. 1999. PMID: 26142373
-
Latinas, amniocentesis and the discourse of choice.Cult Med Psychiatry. 2000 Sep;24(3):353-75. doi: 10.1023/a:1005671703311. Cult Med Psychiatry. 2000. PMID: 11012104
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical